Founders hear the same line all the time: the landlord pays the broker, so the broker is free. In healthcare real estate, that belief creates a dangerous blind spot. Your broker may know the market. They may even bring you a strong location. But that does not mean they are built to protect your timeline, your capital, or your clinical strategy.
- You get pushed to raise your offer because the building is a “home run,” even when the location works better than the build-out ever will.
- You only see listed availabilities because no one is asking what else may open up in the building or off market.
- You get pressured to shorten contingency periods so the owner will “pick your deal.”
- You confuse deal momentum with strategic progress, then inherit the operational consequences for the next decade.
The result: founders hand a major strategic decision to someone whose compensation improves when the deal gets done, not when the site actually supports the care model.
This is not an argument that every broker is reckless or self-interested. Many work hard and genuinely want a good outcome. The problem is more structural than personal. When the business model rewards speed and signed paper, founders should expect pressure toward faster decisions, fewer obstacles, and cleaner transactions. That is exactly where healthcare projects get into trouble.
"In healthcare real estate, the risk is not that your broker is malicious. It is that they are paid to close, while you are the one who has to operate the space."
The Incentive Problem Is Structural, Not Personal
Traditional brokerage compensation is tied to transaction value. Bigger deal, longer term, faster path to execution. That structure does not automatically produce bad advice, but it does create a predictable bias: reduce friction, keep momentum, and get the lease signed.
For a healthcare founder, that is a problem. Your job is not to win a deal. Your job is to make sure the site can support patient flow, staffing, licensing, privacy, infrastructure, and long-term flexibility. The same site selection framework that helps founders move faster also helps them slow down where it matters. A healthcare site is not just an address. It is a clinical operating system in physical form.
That is why the wrong site can look efficient in a tour, competitive in an LOI, and still become a cash drain after signature. We see this most often when founders confuse a good corner, strong demographics, or landlord responsiveness with true healthcare readiness.
Where the Misalignment Shows Up Before You Even Sign
1. Price pressure replaces strategic discipline
One of the clearest signals is emotional pressure around the deal itself. A broker tells you the building is a “home run.” Then comes the next step: raise your offer, move faster, make the proposal more aggressive, do what it takes to win the space.
Example: a site can absolutely be a home run on location and still be a highly flawed healthcare deal. If the infrastructure is weak, the path to medical use is difficult, or the build-out is unusually expensive, “winning” the deal only means you won the right to take on more risk.
Founders need someone willing to separate location quality from execution reality. Those are not the same thing. In our world, we would rather lose a shiny site than win a lease that quietly blows up the pro forma six months later.
2. Market coverage stops at what is easy to show
Another common issue is shallow sourcing. A founder assumes the broker has canvassed the building, asked ownership about shadow inventory, explored near-term rollover, and pressure-tested adjacent options. In reality, some tenant searches stay constrained to what is already listed.
Example: in a multi-tenant building, asking only about posted availability can cause you to miss better suites, upcoming move-outs, or combinations that would solve your space program more cleanly.
For founders, this matters because healthcare footprints are rarely plug-and-play. Sometimes the best deal is not the listed suite. It is the unlisted one becoming available in 90 days, the smaller footprint that lowers burn, or the adjacent space that creates future optionality. That is why we push beyond the listing sheet, just as we push founders to evaluate qualitative site factors that never show up in a rent comp.
3. Contingencies get treated like obstacles instead of protection
The most dangerous version shows up at the LOI stage. To make your offer more attractive, you are asked to shorten diligence periods, reduce regulatory contingencies, compress permitting timelines, or remove protections that feel inconvenient to the landlord.
Example: we have seen pressure to reduce contingency periods simply to make a healthcare deal look cleaner to ownership. We do not allow clients to do that, because the downside is obvious: you can end up with a signed lease, an unusable site, and a 10-year obligation you cannot operationalize.
That is not hypothetical theater. It is exactly how founders get trapped. A non-healthcare tenant may be able to absorb ambiguity. A healthcare founder usually cannot. Licensing pathways, medical use approvals, landlord work letters, MEP capacity, and accessibility issues all need real time to evaluate. That is why we often tell founders to read the LOI as the first operating risk document, not just the first deal document. The same logic shows up in our thinking on the true cost of scaling: the expensive mistake is usually the one that looked efficient at the beginning.
Why This Is More Dangerous in Healthcare
A traditional office tenant can survive more ambiguity. A healthcare founder has less margin for error. You are not simply leasing square footage. You are translating a care model into built form, under regulatory and operational constraints that can punish bad assumptions.
Real Estate Impact
When founders move too fast in healthcare real estate, the consequences hit three times: in capital, in timeline, and in operations.
What this means for your next lease: you cannot let LOI speed outrun diligence. The wrong shortcut at the front end can create a site that is harder to permit, harder to build, and harder to run.
- Zoning or medical-use friction can delay launch long after the lease is signed.
- Undervetted infrastructure can trigger major HVAC, plumbing, or electrical upgrades during design.
- Weak contingency language can leave you holding a long-term obligation on a site you cannot open.
And even when the deal technically works, you can still lose strategically. Founders end up over-spaced, over-rented, or locked into terms that limit future flexibility. That is why our work is never just about finding a site. It is about making sure the site supports how care actually happens, how teams actually work, and how the organization may evolve over the next five to ten years. The same principle drives our work on design decisions that create ripple effects: early choices become long-term operating realities.
The Better Model: Alignment Over Transaction
The right question is not whether brokers are good or bad. The right question is who owns the strategy. If your real estate lead is compensated primarily when the deal closes, you should expect transaction bias. If your advisor is retained to protect your capital and guide the full process, you get a very different behavior set.
Traditional Broker Dynamic
The transaction is the finish line. Advice tends to favor momentum, cleaner LOIs, less friction, and a faster path to signature. That can work for simple deals. It is a weak model for complex healthcare expansion.
Retained Strategic Partner
The operating outcome is the finish line. Advice can favor smaller footprints, deeper diligence, tougher questions, and walking away from bad sites because the goal is not to get paper signed. The goal is to build a viable clinical engine.
That is the core value of a retained advisory or fractional VP of real estate model. We are not trying to rescue every deal. We are trying to make sure founders do not commit to the wrong one. That changes everything. It changes how we evaluate risk, how we negotiate contingencies, how we source options, and how quickly we are willing to move.
Sometimes that means pushing harder. Sometimes it means slowing the process down. Sometimes it means killing a deal that looks exciting on paper. In healthcare, discipline is often the thing that preserves speed later. Founders do not need someone to cheerlead the deal. They need someone willing to challenge it.
The Bottom Line
The broken part of the brokerage model is not that every broker gives bad advice. It is that founders often assume the person moving the deal forward is also protecting the strategy. In healthcare, those are not automatically the same thing.
For healthcare founders: if you outsource site strategy to a transaction model, do not be surprised when the process prioritizes speed over diligence and signature over long-term fit.
For growth-stage operators: the more sites you plan to build, the more expensive this misalignment becomes. One bad lease does not stay one bad lease. It compounds across capital planning, operations, and future rollout decisions.
Before You Sign the Next LOI, Stress-Test the Strategy
We help healthcare founders evaluate sites the way operators should, not the way transactions usually do.
We'll walk through:
- Whether the site actually supports your care model and throughput goals
- Which diligence items need protection before you commit in the LOI
- Where infrastructure, entitlement, or permitting risk may be hiding
- How to structure the process so speed does not come at the expense of viability
